About this raise: Bioverge, with a valuation of $25 million, is raising funds on Republic. The company has developed a health technology investment platform to merge sci-fi with fintech. The platform is democratizing investing in curated healthcare technology startups with its portfolio of 37 companies with a value of over $3 billion. Bioverge offers a variety of investment options, including deal-by-deal investments, Bioverge Access funds, and thematic funds. Neil Littman and Rick Gibb founded Bioverge in August 2017. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for product development, sales and marketing, new hires, and working capital.
Investment Overview
Invested : $138,007
Deal Terms
Total Commitments ($USD)
- Platform
- Republic
- Start Date
- 05/12/2023
- Close Date
- 08/07/2023
$25,000
$1,235,000
$100
SAFE
Seed
RegCF
$18,000,000
$25,000,000
20%
Company & Team
Company
- Year Founded
- 2017
- Industry
- Financial & Insurance Products & Services
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- High
- Capital Intensity
- Low
Financials
- Revenue -1.6% YoY
- $247,786
- Monthly Burn
- $33,850
-
Runway
- 9.6 months
- Gross Margin
- 80%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $2,300,000
- VC Backed?
- Yes
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.